rs747905422
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 16P and 4B. PVS1PP5_Very_StrongBS2
The NM_007272.3(CTRC):c.85C>T(p.Arg29*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000023 in 1,611,576 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R29R) has been classified as Likely benign.
Frequency
Consequence
NM_007272.3 stop_gained
Scores
Clinical Significance
Conservation
Publications
- hereditary chronic pancreatitisInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CTRC | ENST00000375949.5 | c.85C>T | p.Arg29* | stop_gained | Exon 2 of 8 | 1 | NM_007272.3 | ENSP00000365116.4 | ||
| CTRC | ENST00000375943.6 | c.40+1840C>T | intron_variant | Intron 1 of 4 | 1 | ENSP00000365110.2 | ||||
| CTRC | ENST00000476813.5 | n.52+1840C>T | intron_variant | Intron 1 of 2 | 3 | |||||
| CTRC | ENST00000483406.1 | n.-6C>T | upstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152068Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000122 AC: 3AN: 246214 AF XY: 0.0000225 show subpopulations
GnomAD4 exome AF: 0.0000240 AC: 35AN: 1459508Hom.: 0 Cov.: 34 AF XY: 0.0000262 AC XY: 19AN XY: 725850 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152068Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74292 show subpopulations
ClinVar
Submissions by phenotype
Hereditary pancreatitis Pathogenic:3
The p.R29* pathogenic mutation (also known as c.85C>T), located in coding exon 2 of the CTRC gene, results from a C to T substitution at nucleotide position 85. This changes the amino acid from an arginine to a stop codon within coding exon 2. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
This sequence change creates a premature translational stop signal (p.Arg29*) in the CTRC gene. It is expected to result in an absent or disrupted protein product. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This variant has not been reported in the literature in individuals with CTRC-related disease. Loss-of-function variants in CTRC are known to be pathogenic (PMID: 22942235). For these reasons, this variant has been classified as Pathogenic. -
- -
not provided Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at